Contact this trialFirst, we need to learn more about you.
Norepinephrine Reuptake Inhibitor
Atomoxetine +1 More for Alcoholism
Recruiting0 awardsPhase 2
Providence, Rhode Island
This trial is testing whether a drug called atomoxetine, plus therapy, can help reduce alcohol use in teens with an alcohol use disorder. The trial will also use a human laboratory paradigm and ecological momentary assessment (EMA) methods to study how atomoxetine affects intermediate phenotypes associated with alcohol use and outcomes in clinical trials.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.